Published September 1, 2022 | Version Accepted Version

Predicting Human Fetal Drug Exposure Through Maternal‐Fetal PBPK Modeling and In Vitro or Ex Vivo Studies

Description

This is the peer reviewed version of the following article: [Predicting Human Fetal Drug Exposure Through Maternal‐Fetal PBPK Modeling and In Vitro or Ex Vivo Studies. The Journal of Clinical Pharmacology 62, S1 (2022)], which has been published in final form at https://doi.org/10.1002/jcph.2117. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions: https://authorservices.wiley.com/author-resources/Journal-Authors/licensing/self-archiving.html#3.

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

Manuscript_File_for_OA.pdf

Files (841.4 kB)

Name Size Download all
md5:b011d111cff4acb27c4ef9fef7faa209
841.4 kB Preview Download

Additional details

Related works

Is identical to
10.1002/jcph.2117 (DOI)